Committee for Orphan Medicinal Products (COMP): 17-19 May 2016
Date:
17/05/2016 to 19/05/2016
Location:
European Medicines Agency, London, UK
The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.
-
List item
Minutes of the COMP meeting 17-19 May 2016 (PDF/308.31 KB)
Adopted
First published: 30/06/2016
Last updated: 30/06/2016
EMA/COMP/339164/2016 -
List item
COMP meeting report on the review of applications for orphan designation: May 2016 (PDF/127.25 KB)
First published: 01/06/2016
Last updated: 01/06/2016
EMA/COMP/331689/2016 -
List item
Agenda - COMP agenda of the 17-19 May 2016 meeting (PDF/192.06 KB)
Draft
First published: 19/05/2016
Last updated: 19/05/2016
EMA/COMP/292880/2016